Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Costs of screening are important.

Edgell C.

BMJ. 1993 Mar 20;306(6880):797. No abstract available.

2.

Screening for neuroblastoma.

Duncan MH.

BMJ. 1993 Jan 9;306(6870):143-4. No abstract available.

3.

Costs of prevention. Prevention encompasses more than screening.

Khaw KT.

BMJ. 1996 Mar 16;312(7032):708. No abstract available.

4.

Estimating the cost effectiveness of screening tests.

Torgerson DJ, Reid DM.

QJM. 1997 Oct;90(10):649-52.

5.

Screening for secondary causes of hyperlipidaemia in general practice. History should be considered before screening.

Schwandt P, Richter WO.

BMJ. 1994 Nov 19;309(6965):1374; author reply 1374-5. No abstract available.

6.

Screening for Down's syndrome. Costings are crucial to model.

Whittle M.

BMJ. 2002 Jan 12;324(7329):111. No abstract available.

PMID:
11808521
7.

Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial.

Whynes DK.

Crit Rev Oncol Hematol. 1999 Nov;32(2):155-65. No abstract available.

PMID:
10612015
8.

Screening for secondary causes of hyperlipidaemia in general practice. Correct diagnosis needs to be established.

Reynolds TM, Wierzbicki AS, Feher MD.

BMJ. 1994 Nov 19;309(6965):1373-4; author reply 1374-5. No abstract available.

9.

Diagnosing the undiagnosed with diabetes.

Home PD.

BMJ. 1994 Mar 5;308(6929):611-2. No abstract available.

10.

The cost-effectiveness of screening for oral cancer in primary care.

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F.

Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. Review.

11.

Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.

Brown RE, Breugelmans JG, Theodoratou D, Bénard S.

Curr Med Res Opin. 2006 Apr;22(4):663-70.

PMID:
16684427
12.

Health economics: screening test costs.

Henderson J.

Health Soc Serv J. 1982 Feb 25;92(4785):246-7. No abstract available.

PMID:
10254795
13.

Rethinking established dogma. Screening for health.

Richardson IM.

Br Med J (Clin Res Ed). 1984 Jun 23;288(6434):1887-8. No abstract available.

14.

[Health economics analysis of cervical cancer screening].

Boncz I, Sebestyén A, Pál M, Sándor J, Ember I.

Orv Hetil. 2003 Apr 13;144(15):713-7. Hungarian.

PMID:
12774432
15.

Breast cancer screening and health service costs.

Gravelle HS, Simpson PR, Chamberlain J.

J Health Econ. 1982 Aug;1(2):185-207. No abstract available.

PMID:
10263955
16.

Costs and benefits of cervical screening. I. The costs of the cervical screening programme.

Waugh N, Smith I, Robertson A, Reid GS, Halkerston R, Grant A.

Cytopathology. 1996 Aug;7(4):231-40.

PMID:
8853969
17.

Counting costs of screening.

Lyall J.

Health Serv J. 1986 Nov 20;96(5026):1506. No abstract available.

PMID:
10279720
18.

Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.

Marks D, Thorogood M, Neil HA, Wonderling D, Humphries SE.

J Public Health Med. 2003 Mar;25(1):47-52.

19.

The costs of prevention.

Cairns J.

BMJ. 1995 Dec 9;311(7019):1520. No abstract available.

20.
Items per page

Supplemental Content

Write to the Help Desk